B. Stam, 1 A. Tijhuis, 2 M. Rossi, 1 J. Belderbos, 1 J. Sonke 1 1 Department of Radiation Oncology, The Netherlands Cancer Institute e Antoni Van Leeuwenhoek Hospital, Amsterdam/NL, 2 Radiation Oncology, Netherlands Cancer Institute, Amsterdam/NL Background: In NSCLC patients who receive radiotherapy, cardiac toxicity was not well established as a possible factor until the results of the RTOG 0617 showed associations between cardiac dose and survival. These associations have been confirmed both in early and in locally advanced stage NSCLC patients. Cardiac sparing is not yet systematically pursued, and there is currently no agreement on cardiac constraints to be used. We investigated the feasibility of cardiac sparing in early stage NSCLC patients who receive SBRT. Method: Ten patients with early stage NSCLC in a middle or lower lobe, treated to 3x18 Gy between 2015 and 2017 using a dual arc VMAT technique were randomly selected. Retrospectively, clinical plans were adapted to minimize the maximum heart dose, while clinical constraints were respected. Mean Lung Dose (MLD) and cardiac doses Dmax, Dmean and V 5Gy were compared between clinical and cardiac spared plans using a paired t-test. Result: Median GTV was 3.05cc (range 0.54-23.2cc), 7 left sided tumors, 3 right sided. All cardiac spared plans fulfilled the clinical constraints on tumor coverage, conformity and organs at risk. All cardiac parameters were significantly decreased; a reduction in max heart dose of 8.2 Gy, reduction in mean heart dose of 1.0 Gy, and reduction in heart V 5Gy of 10.3%, with p-values <0.001, 0.008 and 0.014 respectively. MLD was increased by a mean of 0.51 Gy (p-value 0.002). Results are shown in table 1. Conclusion: Cardiac sparing is feasible for early stage NSCLC patients treated with SBRT, without compromising target coverage, and with minimal increase in mean lung dose. As cardiac exposure is associated with increased mortality, cardiac sparing has the potential to increase survival, and should be considered for all early stage NSCLC patients treated with radiotherapy. These data will need to be confirmed in a larger, prospective cohort. Keywords: SBRT, Cardiac sparing, Cardiac toxicity P3.16-18 Modern Radiotherapy Increases Patient Access to Curative Intent Radiotherapy in Non-Small Cell Lung Cancer K. Tumelty, J. Mcaleese, C. Rooney, G. Walls, R. Eakin, J. Harney, L. Young, G. Hanna Northern Ireland Cancer Centre, Belfast/GB Background: Technical developments in the delivery of radiotherapy such as image-guided radiotherapy (IGRT) and intensity modulated radiotherapy (IMRT) have permitted the introduction of advanced radiation techniques such stereotactic ablative radiotherapy (SABR). These new techniques have the advantage of more accurate localisation of the tumour and reduced irradiation of normal tissues. In our centre, we have implemented a range of new techniques to deliver IGRT (such as PET/CT and 4-dimensional CT planning, and cone beam CT during treatment delivery). We postulate that using the advanced techniques increases the access to curative intent radiotherapy treatment of lung cancer. We seek to assess the access rates to curative intent thoracic radiotherapy. Method: Using our institutional lung radiotherapy database we analysed the data recording intent of treatment with reference to the stage and performance status (PS) of all patients with stage 1-3 non-small cell lung cancer (NSCLC) in 2007 and compared this to the same population receiving radiotherapy during 2017 and up to April 2018. Result: In 2007, 217 patients with stages 1-3 NSCLC received any radiotherapy compared to 218 patients for the 2017/ Difference in cardiac and lung doses between clinical plans and cardiac spared plans. Background: With the progress of diagnostic imaging modalities, such as CT and FDG-PET, the number of resectable lung cancer, particularly small peripheral lung cancer, is increasing. We focused on the SUVmax of FDG-PET as a prognostic factor for lung cancer and established criteria for limited resection on the basis of CT findings and SUVmax. Since 2007, we continuously monitored the recurrence and prognosis of non-small cell lung cancers (NSCLCs) resected using our criteria.
Patient
Here, we report the results of this study. Method: Between December 2007 and December 2015, 611 consecutive patients underwent surgery for NSCLC at our institution. Of these, 73patients with cT1aN0M0 who underwent limited resection (partial resection or segmentectomy) were enrolled. The criteria for undergoing limited resection were as follows: ①tumor GGO ratio of 0.75and ② tumor SUVmax of 1.5. GGO ratio was calculated using the following equation: GGO ratio¼ [(maximum diameter of the tumor) e (maximum diameter of tumor consolidation)] / (maximum diameter of the tumor). The group that met our criteria and underwent limited resection was designated as intended limited resection group (ILR group), and the group subjected to limited surgery without meeting the criteria treated as control group. Result: The study included 35 men and 38 women with a median age of 65 (range, 36e84) years. In total, 51 patients who met our criteria were included in the ILR group, and 21 patients who did not meet the criteria were included in the control group. The control group was selected for limited resection in terms of complications, pulmonary hypofunction, and heart failure. Regarding surgical approach, in the ILR group, 19 patients underwent partial resection and 32 underwent segmentectomy; in the control group, 13 patients underwent partial resection and 8 underwent segmentectomy. According to our criteria, no relapsed cases were reported in the ILR group. Moreover, the 5-year overall survival rates of the ILR and control groups were 100% and 60.5%, respectively, and the disease-free survival rates were 100% and 56.0%, respectively, indicating a significant difference (P < 0.0001). In the control group, 6 patients showed the recurrence of lung cancer. Conclusion: In this study, we analyzed the feasibility of our criteria for performing limited resection on the basis of CT findings and SUVmax.
In the ILR group, no relapsed cases were reported, suggesting that our criteria may be useful in determining patient's eligibility for undergoing reduction surgery. Keywords: NSCLC, limited resection, GGO P3.16-21 Robotic Thoracic Surgery in Lung Cancer Resection e A Comprehensive Review P. Balakrishnan Cardiothoracic Department, Wellington Regional Hospital, Wellington/NZ Background: Minimally invasive VATS thoracic surgery is currently the gold standard approach for most thoracic procedures . It has come a long way since major maximally invasive thoracotomy approaches . Minimally invasive thoracic procedures indefinitely has its distinctive positive outcomes and other secondary benefits to patients and surgeons . Introduction of robotic technique into thoracic surgery has brought huge advantage to patients and surgeons as well as maximised treatment modalities more efficiently . In the review , we will look into the state of art robotic thoracic surgeries available , feasibility , outcomes , accessibility and costs and the pitfalls . Method: A extensive literature search was performed using MEDLINE ,OVID and PUBMED search databases in the last 10 years . A retrospective review and metaanalysis of these papers were conducted using matched-pair analyses and propensity matched scoring and standard statistical analysis . A total of 43 papers were reviewed and a meta-analysis of these studies in terms of feasibility , outcomes , accessibility and costs and the pitfalls were looked into . A summary review into the current state of robotic thoracic surgery , with the its current limitations and future adaptations were also looked into Result: pending data collection and interpretation . Applied late-breaking abstract Conclusion: pending -applied late-breaking abstract Keywords: robotic thoracic surgery , NSCLC , advances in Lung resection
